These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20569656)

  • 21. Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey.
    Erim Y; Tagay S; Beckmann M; Bein S; Cicinnati V; Beckebaum S; Senf W; Schlaak JF
    Int J Nurs Stud; 2010 Mar; 47(3):342-9. PubMed ID: 19766994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline Comorbidities Enhance the Risk of Treatment-Induced Depression in HCV-Infected Men: A Pilot Study.
    Rempel JD; Krueger C; Minuk GY; Wong SG
    Am J Mens Health; 2014 Sep; 8(5):427-33. PubMed ID: 24493076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors.
    McAndrews MP; Farcnik K; Carlen P; Damyanovich A; Mrkonjic M; Jones S; Heathcote EJ
    Hepatology; 2005 Apr; 41(4):801-8. PubMed ID: 15793853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.
    Raison CL; Broadwell SD; Borisov AS; Manatunga AK; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
    Brain Behav Immun; 2005 Jan; 19(1):23-7. PubMed ID: 15581735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression, anemia and health-related quality of life in chronic hepatitis C.
    Dan AA; Martin LM; Crone C; Ong JP; Farmer DW; Wise T; Robbins SC; Younossi ZM
    J Hepatol; 2006 Mar; 44(3):491-8. PubMed ID: 16427157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impaired cognitive function in hepatitis C virus infection].
    Renvillard SG; Leutscher PD; Hjerrild S; Videbech P
    Ugeskr Laeger; 2010 Feb; 172(5):372-6. PubMed ID: 20122332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
    Ferenci P; Staufer K
    Liver Int; 2008 Apr; 28(4):429-31. PubMed ID: 18339069
    [No Abstract]   [Full Text] [Related]  

  • 28. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment.
    Kelly EM; Corace K; Emery J; Cooper CL
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):811-6. PubMed ID: 22495398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of disease in U.S. veteran patients with hepatitis C.
    Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
    Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.
    Leutscher PD; Lagging M; Buhl MR; Pedersen C; Norkrans G; Langeland N; Mørch K; Färkkilä M; Hjerrild S; Hellstrand K; Bech P;
    Hepatology; 2010 Aug; 52(2):430-5. PubMed ID: 20683942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression in late life. Diagnosis, course, and consequences.
    Zisook S
    Postgrad Med; 1996 Oct; 100(4):143-8, 150, 156. PubMed ID: 8858088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.
    Frydecka D; Pawłowski T; Pawlak D; Małyszczak K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):169-175. PubMed ID: 28083615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
    Baranyi A; Meinitzer A; Putz-Bankuti C; Stauber R; Kapfhammer HP; Rothenhäusler HB
    Psychosom Med; 2014 Apr; 76(3):197-207. PubMed ID: 24608038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.
    Nunes D; Saitz R; Libman H; Cheng DM; Vidaver J; Samet JH
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1520-6. PubMed ID: 16930214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt.
    Bassiony MM; Yousef A; Raya Y; El-Shabrawi A; Fouad E; El-Shafeey M
    Int J Psychiatry Clin Pract; 2015; 19(3):208-15. PubMed ID: 26099337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury.
    Wilson MP; Castillo EM; Batey AM; Sapyta J; Aronson S
    Int J Psychiatry Med; 2010; 40(2):199-215. PubMed ID: 20848876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.
    Liu SS; Schneekloth TD; Talwalkar JA; Kim WR; Poterucha JJ; Charlton MR; Wiesner RH; Gross JB
    J Clin Gastroenterol; 2010 Sep; 44(8):e178-85. PubMed ID: 20495464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.